Medical Patent News

RSS

Invitrogen and Agilent Technologies resolve all pending patent litigations

Invitrogen Corporation and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies.

5 Feb 2008

U.S. PTO's rejection of Gilead's antiretroviral patents might affect applications in India

Last week's rejection by the U.S. Patent and Trademark Office of four patents on Gilead Sciences' antiretroviral drug Viread might affect patent applications for the drug in India, the Times of India reports.

28 Jan 2008

Applied DNA Sciences files patents for optical DNA SigNature markers

Applied DNA Sciences, Inc. has announced that it has filed multiple patent applications to cover its latest developments in optical reporter markers.

23 Jan 2008

Ranbaxy settles with GlaxoSmithKline on Imitrex

Ranbaxy Laboratories Limited (Ranbaxy) has announced that it has settled all matters relating to possible patent litigation with GlaxoSmithKline relating to Sumatriptan Succinate Tablets, the generic version of GlaxoSmithKline's Imitrex Tablets.

22 Jan 2008

New patent for massage tool

When 10-year veteran massage therapist Greg Polins, of PolTech, Inc., began to experience crippling pain in his thumbs and wrists from extensive deep tissue massage, he knew he had to do something to keep his job.

17 Jan 2008

2007's top U.S. patent assignees

IFI Patent Intelligence, a Wolters Kluwer Health business, today announced its annual compilation of the world's top-ranked U.S. patent winners.

15 Jan 2008

Barr Pharmaceuticals confirms patent challenge of Namenda tablets

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Forest Laboratories, Inc. in connection with its Namenda (memantine hydrochloride) tablets, 5mg and 10mg.

14 Jan 2008

Cynosure files patent infringement against CoolTouch

Cynosure, Inc., a developer and manufacturer of a broad array of light-based aesthetic treatment systems, and its largest shareholder, El.En. S.p.A., today filed a patent infringement lawsuit against CoolTouch Inc. in U.S. District Court for the District of Massachusetts.

10 Jan 2008

Barr Pharmaceuticals confirms Eloxatin injectable patent challenge

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, has initiated a challenge of the patents listed by Sanofi-Aventis U.S. LLC in connection with its Eloxatin(R) (Oxaliplatin Aqueous Solution), 5mg/mL Injectable.

10 Jan 2008

Nastech receives U.S. patent for methods for identifying cell-specific targeting peptides

Nastech Pharmaceutical Company Inc. has announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application No. 10/976,942, entitled "Phage Displayed Trp Cage Ligands".

9 Jan 2008

Patent granted for motorcycle cancer seat

The United Kingdom has granted a patent to Canadian inventor Randall Dale Chipkar for his innovative 'electromagnetic shielding motorcycle seat'.

9 Jan 2008

USPTO orders re-examination of two patents included in the patent litigation between Illumina and Affymetrix

Illumina, Inc. has announced that the United States Patent and Trademark office has ordered the re-examination of U.S. Patent Nos. 6,355,432 and 6,646,243.

From Illumina, Inc. 28 Dec 2007

New patent law has consequences for the pharmaceutical industry

On 13th December 2007 a revised version of the European Patent Convention (EPC) came into force. This new law, known as EPC2000, has a number of consequences for the pharmaceutical industry and the way in which patent applications are examined.

20 Dec 2007

Sensory Analytics receives new coating measurement patent

Sensory Analytics, an emerging leader in non-contact and non-destructive coating measurement systems, today announced the issuance of the company ' s third patent, United States Patent 7,274,463.

18 Dec 2007

Barr sues Watson and Sandoz for Seasonale patent infringement

Barr Pharmaceuticals, Inc. (NYSE:BRL) today announced that its wholly-owned subsidiary, Duramed Pharmaceuticals, Inc. has filed suits against Watson Pharmaceuticals (NYSE:WPI) and against Sandoz, a subsidiary of Novartis (NYSE:NVS) for infringement of the patent protecting Duramed's SEASONALE(R) extended-cycle oral contraceptive product.

17 Dec 2007

Odyssey Thera granted U.S. patent for animal imaging

Odyssey Thera, Inc. has announced that the United States Patent and Trademark Office granted U.S. Patent No. 7,306,914, entitled "Protein-fragment Complementation Assays (PCA) in whole animals: applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy.

13 Dec 2007